Back to Search
Start Over
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma
- Source :
- Transplantation and Cellular Therapy; November 2022, Vol. 28 Issue: 11 p752.e1-752.e6, 6p
- Publication Year :
- 2022
-
Abstract
- •This was a retrospective analysis of 231 patients with a high-risk chromosomal abnormality (HRMM) receiving lenalidomide (Len)-based post-transplantation maintenance.•Maintenance with Len-based combinations did not improve outcomes in the entire cohort.•In patients with HRMM other than 1q+, there was a trend toward improved PFS with Len-based combinations for maintenance.
Details
- Language :
- English
- ISSN :
- 26666375 and 26666367
- Volume :
- 28
- Issue :
- 11
- Database :
- Supplemental Index
- Journal :
- Transplantation and Cellular Therapy
- Publication Type :
- Periodical
- Accession number :
- ejs61353626
- Full Text :
- https://doi.org/10.1016/j.jtct.2022.07.028